1) Dengue fever is a mosquito-borne tropical disease caused by the dengue virus and spread by several species of mosquito, principally Aedes aegypti.
2) Infection with one dengue virus type usually gives lifelong immunity to that type but only short-term immunity to others, and subsequent infection with a different type increases the risk of severe complications.
3) Aedes aegypti and Aedes albopictus are the two most prominent mosquito species that transmit viruses causing dengue fever, yellow fever, West Nile fever, chikungunya, eastern equine encephalitis, and Zika virus.
The Paramyxoviridae is a family of single-stranded RNA viruses known to cause different types of infections in vertebrates. Examples of these infections in humans include the measles virus, mumps virus, parainfluenza virus, and respiratory syncytial virus (RSV).
The new virus has made the jump from pigs to humans and has demonstrated it can also pass from human to human. This is why it is demanding so much attention from health authorities. The virus passes from human to human like other types of flu, either through coughing, sneezing, or by touching infected surfaces, although little is known about how the virus acts on humans.
The Paramyxoviridae is a family of single-stranded RNA viruses known to cause different types of infections in vertebrates. Examples of these infections in humans include the measles virus, mumps virus, parainfluenza virus, and respiratory syncytial virus (RSV).
The new virus has made the jump from pigs to humans and has demonstrated it can also pass from human to human. This is why it is demanding so much attention from health authorities. The virus passes from human to human like other types of flu, either through coughing, sneezing, or by touching infected surfaces, although little is known about how the virus acts on humans.
My Presentation in College.
Hope its useful for you rather than sleeping in my desktop.
Sorry if there is any mistakes.
The presentation is about Dengue fever. First starting with the basic information like Introduction , Epidemiology ,Vector , Viral Morphology ,Mode of Transmission. Then little bit on Pathogenesis and Immune Response. Extra focus given to the Clinical Manifestations, symptoms and Lab Diagnosis with few simplified case studies. Control and prevention and treatment also included.
This lecture presentation contains description of arbovirus particularly detailing Dengue virus infections. Lecture outlined general characteristics of Arbovirus, classification of Arboviruses, salient features of Dengue virus, dengue pathogenesis, clinical course, laboratory diagnosis, complications of secondary dengue and some recent aspect of dengue vaccine preparation.
My Presentation in College.
Hope its useful for you rather than sleeping in my desktop.
Sorry if there is any mistakes.
The presentation is about Dengue fever. First starting with the basic information like Introduction , Epidemiology ,Vector , Viral Morphology ,Mode of Transmission. Then little bit on Pathogenesis and Immune Response. Extra focus given to the Clinical Manifestations, symptoms and Lab Diagnosis with few simplified case studies. Control and prevention and treatment also included.
This lecture presentation contains description of arbovirus particularly detailing Dengue virus infections. Lecture outlined general characteristics of Arbovirus, classification of Arboviruses, salient features of Dengue virus, dengue pathogenesis, clinical course, laboratory diagnosis, complications of secondary dengue and some recent aspect of dengue vaccine preparation.
Dengue (pronounced DENG-gay) can affect anyone but tends to be more severe in people with compromised immune systems. Because it is caused by one of four serotypes of virus, it is possible to get dengue fever multiple times. However, an attack of dengue produces immunity for a lifetime to that particular serotype to which the patient was exposed.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
How to Give Better Lectures: Some Tips for Doctors
Dengue fever
1. Dengue fever
BY:
Dr, WALAA SALAH MANAA
SPECIALEST OF PEDIATRIC & FEVER
ـيخشالـفرك ـياتمحـستشفىم
2. Dengue fever is a mosquito-borne tropical
disease caused by the dengue virus
Dengue is spread by several species of mosquito of
the Aedes type, principally A. aegypti. The virus has
five different types; infection with one type usually
gives lifelong immunity to that type, but only short-
term immunity to the others.
Subsequent infection with a different type increases
the risk of severe complications
3. About half a million people require admission to
hospital a year.
(NSAIDs) such as ibuprofen should not be
used
Dengue has become a global problem since
the Second World War and is common in more than
110 countries
Each year between 50 and 528 million people are
infected and approximately 10,000 to 20,000 die
The earliest descriptions of an outbreak date from
1779.
4. Dengue fever virus (DENV) is an RNA virus of the
family Flaviviridae; genus Flavivirus.
Other members of the same genus include yellow fever
virus, West Nile virus, St. Louis encephalitis
virus, Japanese encephalitis virus, tick-borne encephalitis
virus, Kyasanur forest disease virus, and Omsk
hemorrhagic fever virus.
Most are transmitted by arthropods (mosquitoes
or ticks), and are therefore also referred to
as arboviruses(arthropod-borne viruses).
Virology
5. There are 5 serotypes, of which the first four are
referred to as DENV-1, DENV-2, DENV-3 and DENV-4.
The fifth type was announced in 2013.
one serotype is thought to produce lifelong immunity to that
type, but only short-term protection against the other three.
The risk of severe disease from secondary infection increases
if someone previously exposed to other serotype
6. Fact 1: Females Are the Ones that Bite and Transmit Disease
Fact 2: Aedes aegypti Strike During the Day
Fact 3: Aedes aegypti are Becoming Resistant to
Insecticides
Fact 4: Aedes aegypti Love Your Home Just as Much
as You Do
Fact 5: Aedes aegypti are Highly Invasive
Five Facts You Need to Know about Aedes aegypti
July 14, 2016
7. Other Aedesspecies that transmit the
disease include
A. albopictus,
A. polynesiensis
A. scutellaris.
18. The two most prominent
species that transmit
viruses are Aedes
aegypti and Aedes
albopictus which transmit
the viruses that cause
1-dengue fever,
2-yellow fever
3-West Nile fever
4-chikungunya,
5-eastern equine encephalitis, and
6-Zika virus
along with many other, less notable diseases.
Infections with these viruses are typically
accompanied by a fever, and, in some cases,
encephalitis, which can lead to death.
19.
20.
21.
22.
23.
24. transmitted via infected blood products through organ donation.
In countries such as Singapore, where dengue is endemic, the risk
is estimated to be between 1.6 and 6 per 10,000 transfusions.
Vertical transmission during pregnancy or at birth has been
reported.
person-to-person modes of transmission have also been reported,
but are very unusual.
Dengue can also be
26. why secondary infection with a different
strain of dengue virus places people at risk
of dengue hemorrhagic fever and dengue
shock syndrome.
The most widely accepted hypothesis is
that of
antibody-dependent enhancement
32. asymptomatic
(80%) or have only mild symptoms such as an uncomplicated
fever.
Others have more severe illness (5%)
and in a small proportion it is life-threatening
incubation period
ranges from 3 to 14 days, but most often it is 4 to 7 days.
33. Therefore, travelers returning from endemic areas are
unlikely to have dengue if fever or other symptoms start
more than 14 days after arriving home.
34. Children often experience symptoms similar to those
of the common cold and gastroenteritis (vomiting and
diarrhea)
and have a greater risk of severe complications,
though initial symptoms are generally mild but
include high fever.
35.
36. The characteristic symptoms of dengue are
sudden-onset fever, headache ,
retro orbital pain,
muscle and joint pains, and a rash.
The alternative name for dengue, "breakbone
fever", comes from the associated muscle and
joint pains
The course of infection is divided into three
phases: febrile, critical, and recovery
37. 1- febrile phase
high fever, potentially over 40 °C, and is
associated with generalized pain and a
headache; this usually lasts 2-7days
Nausea and vomiting may also occur.
The fever itself is classically biphasic or
saddleback in nature, breaking and then
returning for one or two days.
38. A rash occurs in 50–80% of those with symptoms
In the first or second day of symptoms as flushed skin, or
later in the course of illness (days 4–7), as a measles-like
rash.
Some petechiae can appear at this point,as may some mild
bleeding from the the mouth and nose
39.
40. Warning signs typically occur
before the onset of severe
dengue.
A probable diagnosis is based on the findings
of fever plus 2 of the following:
nausea and vomiting, rash, generalized
pains, low white blood cell count,
positive tourniquet test, or any warning sign
1-Worsening of abdominal pain
2-persistent vomiting.
3- hepatomegally.
4-mucosl bleeding.
5-high hematocrit low platelets
6-serosal effusion.
41. is present if pulse pressure drops to ≤ 20 mm Hg
along with peripheral vascular collapse.
Peripheral vascular collapse is determined in
children via delayed capillary refill, rapid heart rate,
or cold extremities.
warning signs are an important aspect for early
detection of potential serious disease.
Dengue shock syndrome
42. Grades III and IV are referred to as
"dengue shock syndrome
Dengue hemorrhagic
fever was subdivided
further into
Grade I is the presence only of easy bruising or a positive
tourniquet test in someone with fever,
grade II is the presence of spontaneous bleeding into the
skin and elsewhere,
grade III is the clinical evidence of shock
and grade IV is shock so severe that blood pressure
and pulse cannot be detected.
43. In some people, the disease proceeds to a critical phase as fever
resolves.
During this period, there is leakage of plasma from the blood
vessels, typically lasting 1-2 days.
This may result in ascitis and pleural effusion
as well as depletion of fluid from the circulation and decreased
blood supply to vital organs
There may also be organ dysfunction and severe bleeding,
2-critical phase
44. Shock (dengue shock syndrome) and hemorrhage
(dengue hemorrhagic fever) occur in less than 5%
of all cases of dengue,
however those who have previously been infected
with other serotypes of dengue virus ("secondary
infection") are at an increased risk.
This critical phase, while rare, occurs relatively
more commonly in children and young adults.
45. 3-The recovery phase
The recovery phase occurs next, with resorption of the leaked fluid into
the bloodstream. This usually 2-3 days.
The improvement is often striking, and can be accompanied with
severe itching and a slow heart rate.
Another rash may occur with either a maculopapular or a vasculitic
appearance, which is followed by peeling of the skin.
During this stage, a fluid overload state may occur; if it affects the brain,
it may cause a reduced level of consciousness or seizures.
A feeling of fatigue may last for weeks in adults.
46. The rash that commonly forms during the
recovery from dengue fever with its classic
islands of white in a sea of red.
47. 1-A decreased level of consciousness occurs in 0.5–6% of severe
cases, which is due to either
viral encephalitis or indirectly as a result of impairment of vital
organs, for example, the liver.
2-CNS disorders have been reported, such as transverse
myelitis and Guillain–Barré syndrome,
3- acute liver failure are among the rarer complications.
4-A pregnant woman who develops dengue may be at a higher
risk of abortion as well as LBW and premature birth.
Associated problems
48. risk factors for severe disease
1-babies and young children
2-female,
3-high body mass index,
3- high viral load.
4-chronic diseases such as diabetes and asthma]
49.
50.
51. laboratory investigations
Leucopenia ,thrompocytopenia and metabolic acidosis
moderately elevated level of (AST and ALT) from the liver is common.
In severe disease, plasma leakage results
in hemoconcentration (rising hematocrit) and hypoalbuminemia.
Pleural effusions or ascites can be detected by physical examination when
large, but the demonstration of fluid on ultrasound may assist in the early
identification of dengue shock syndrome.
virus isolation in cell cultures, PCR
56. There are no specific antiviral drugs for dengue,
however maintaining proper fluid balance is important
Treatment depends on the symptoms.
Those who are able to drink, are passing urine, have no
"warning signs" and are otherwise healthy can be managed
at home with daily follow up and oral rehydration therapy
Those who have other health problems, have "warning
signs", or who cannot manage regular follow-up should be
cared for in hospital.[
In those with severe dengue care should be provided in an
area where there is access to an intensive care unit
57. IV fluid, if required, is typically only needed for1-2
days.
In children with shock due to dengue a rapid dose of
20mL/kg is reasonable.
The rate of fluid administration is than titrated to
a urinary output of 0.5–1 mL/kg/h, stable vital
signs and normalization of hematocrit.
The smallest amount of fluid required to achieve this
is recommended
58. Invasive medical procedures
such as nasogastric
intubation, intramuscular
injections and arterial
punctures are avoided, in
view of the bleeding risk.[
Paracetamol is used for
fever and discomfort
while NSAIDs such
as ibuprofen and aspirin are
avoided as they might
aggravate the risk of
bleeding
59. Dengue fever – do not give Aspirin or
Ibuprofen to the patient
The infecting organism in dengue affects the
platelets which are responsible for clotting (stopping
bleeding) increasing the tendency of the person to
bleed.
Aspirin and Ibuprofen also have similar action. Both
of them together could cause the person to bleed
excessively pushing the patient into what is called
the ‘Dengue Shock syndrome’.
And once in this stage, medical treatment is needed
in an emergency basis and hospitalization becomes
necessary.
60. Blood transfusion is initiated early in
people presenting with unstable vital
signs in the face of a decreasing
hematocrit.[
Packed red blood cells or whole
blood are recommended,
while platelets and fresh frozen
plasma are usually not.
There is not enough evidence to
determine if corticosteroids have a
positive or negative effect in dengue
fever
61. During the recovery phase intravenous fluids
are discontinued to prevent a fluid
overload.
If fluid overload occurs and vital signs are
stable, stopping further fluid may be all that
is needed.
If a person is outside of the critical phase,
a loop diuretic such as furosemide may be
used to eliminate excess fluid from the
circulation.]